Increase in the Expression of CD4+CD25+ Lymphocytic T Cells in the Indeterminate Clinical Form of Human Chagas Disease After Stimulation With Recombinant Antigens of Trypanosoma cruzi

被引:4
|
作者
de Moura Braz, Suellen Carvalho [1 ]
de Melo, Adriene Siqueira [1 ]
Aureliano de Melo Cavalcanti, Maria da Gloria [2 ,3 ]
Martins, Silvia Marinho [2 ,3 ]
de Oliveira, Wilson, Jr. [2 ,3 ]
da Silva, Edimilson Domingos [2 ,4 ]
Pinto Ferreira, Antonio Gomes [2 ,4 ]
Barros de Lorena, Virginia Maria [1 ,2 ]
Gomes, Yara de Miranda [1 ,5 ]
机构
[1] Programa Integrado Doenca Chagas Fiocruz, Dept Imunol, Rio De Janeiro, Brazil
[2] Programa Integrado Doenca Chagas Fiocruz, Rio De Janeiro, Brazil
[3] Univ Pernambuco UPE, Ambulatorio Doenca Chagas & Insuficiencia Cardiac, Recife, PE, Brazil
[4] Biomanguinhos Fiocruz, Rio De Janeiro, Brazil
[5] Fundacao Oswaldo Cruz Fiocruz, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Imunol, BR-50670420 Recife, PE, Brazil
关键词
Chronic Chagas Disease; repetitive antigens; CD4+CD25+T cells; immunomodulation; IMMUNOLOGICAL SELF-TOLERANCE; IN-VITRO STIMULATION; LIMITED ROLE; INFECTION; CD8(+); CRA; CARDIOMYOPATHY; ANTIBODIES; FREQUENCY; PROTEINS;
D O I
10.1007/s10875-014-0092-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells are involved in the clinical course of chronic Chagas disease, possibly because they exercise a control in the patient's inflammatory response to Trypanosoma cruzi. This study analyzed the levels of CD4 + CD25+ T cells in chronic Chagas disease patients after in vitro stimulation of the peripheral blood mononuclear cells with CRA (Cytoplasmic Repetitive Antigen) or FRA (Flagellar Repetitive Antigen) T. cruzi antigens. Groups of patients with the cardiac form and indeterminate form; and non-infected individuals, were selected. The CD4 + CD25+ T lymphocyte population, as well as the FoxP3 expression and the IL10 production, were evaluated by flow cytometry after stimulation with CRA or FRA. The IND group presented higher levels of CD4 + CD25+ T cells than the CARD group. However, there was no evidence of a relationship between FoxP3 and IL10 with any of the chronic forms. Our results suggest the possible involvement of CD4 + CD25+ T cells specific to CRA and FRA in controlling the progression of clinical outcomes. Though, further studies are needed to define which mechanisms activate regulatory T cells and lead to pathology control in chronic human Chagas disease.
引用
收藏
页码:991 / 998
页数:8
相关论文
共 50 条
  • [11] Isolation of CD4+CD25+ regulatory T cells for clinical trials
    Hoffmann, P
    Boeld, TJ
    Eder, R
    Albrecht, J
    Doser, K
    Pieshka, B
    Dada, A
    Niemand, C
    Assenmacher, M
    Orsó, E
    Andreesen, R
    Holler, E
    Edinger, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (03) : 267 - 274
  • [12] Human CD4+CD25+ regulatory T cells and infectious tolerance
    Stassen, M
    Schmitt, E
    Jonuleit, H
    TRANSPLANTATION, 2004, 77 (01) : S23 - S25
  • [13] MYOCARDIAL TRYPANOSOMA-CRUZI ANTIGENS (AGS) INDUCES INCREASE OF CD8+ BUT NOT OF CD4+ T-CELL NUMBERS IN HUMAN CHRONIC CHAGAS CARDIOPATHY
    HIGUCHI, M
    REIS, M
    GUTIERREZ, P
    AIELLO, V
    CIRCULATION, 1995, 92 (08) : 2245 - 2245
  • [14] Prevention of autoimmune disease by CD4+CD25+ regulatory T cells
    Van Driel, IR
    Zwar, TD
    Allen, S
    Read, S
    Gleeson, PA
    TISSUE ANTIGENS, 2005, 66 (05): : 574 - 575
  • [15] CD4+CD25+ regulatory T cells in human lupus erythematosus
    Annegret Kuhn
    Stefan Beissert
    Peter H. Krammer
    Archives of Dermatological Research, 2009, 301 : 71 - 81
  • [16] CD4+CD25+ regulatory T cells in human lupus erythematosus
    Kuhn, Annegret
    Beissert, Stefan
    Krammer, Peter H.
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2009, 301 (01) : 71 - 81
  • [17] Cytokine Levels in Serious Cardiopathy of Chagas Disease After In Vitro Stimulation with Recombinant Antigens from Trypanosoma cruzi
    Lorena, V. M. B.
    Lorena, I. M. B.
    Braz, S. C. M.
    Melo, A. S.
    Melo, M. F. A. D.
    Melo, M. G. A. C.
    Silva, E. D.
    Ferreira, A. G. P.
    Morais, C. N. L.
    Costa, V. M. A.
    Correa-Oliveira, R.
    Gomes, Y. M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2010, 72 (06) : 529 - 539
  • [18] Isolation of human CD4+CD25+ T cells with regulatory capacity for clinical trials.
    Hoffmann, P
    Eder, R
    Piseshka, B
    Havasi, A
    Orso, E
    Dada, A
    Andreesen, R
    Holler, E
    Edinger, M
    BLOOD, 2004, 104 (11) : 779A - 779A
  • [19] CD4-mediated activation of human CD4+CD25+ regulatory T cells
    Becker, CG
    Wijdenes, J
    Schneider, F
    Knop, J
    Jonuleit, H
    EXPERIMENTAL DERMATOLOGY, 2006, 15 (03) : 204 - 204
  • [20] Increase of CD4+CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma:: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+CD25+ T lymphocytes
    Audia, S.
    Nicolas, A.
    Cathelin, D.
    Larmonier, N.
    Ferrand, C.
    Foucher, P.
    Fanton, A.
    Bergoin, E.
    Maynadie, M.
    Arnould, L.
    Bateman, A.
    Lorcerie, B.
    Solary, E.
    Chauffert, B.
    Bonnotte, B.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 150 (03): : 523 - 530